Certified Clinical Research Coordinator (CCRC) Practice Exam Prep & Study Guide

Verbal consent is allowed by the FDA before participation in a research study primarily when the study involves minimal risk. This stipulation is grounded in ethical considerations and regulatory guidelines that aim to protect research participants while accommodating the nature of certain studies.

In situations where risk is minimal, requiring written consent may be overly burdensome and could hinder participation in studies that are of low risk to subjects. When the research presents little likelihood of harm or discomfort, verbal consent, with appropriate safeguards, can be accepted to streamline the process and foster participant engagement. It is often accompanied by the provision of information about the study and the option to ask questions, ensuring that participants are adequately informed before they consent.

Other options, such as the subject being a minor or research funded by a government agency, do not inherently allow for verbal consent as they involve additional ethical considerations or requirements aimed at protecting vulnerable populations and ensuring compliance with regulatory standards. Moreover, the status of the drug—whether approved or not—doesn't specifically dictate whether verbal consent can be used, as risk assessment is a more critical factor in determining the consent process.